Wu Chang-Lin, He Jian-An, Gu Da-Yong, Shao Yong-Hong, Dang Xi-Tang, Zhu Yi, Wang Shi-Yue, Yi Ping, Shao Chao-Peng
Department of Blood Transfusion, The Second People's Hospital of Shenzhen, Shenzhen 518035, Guangdong Province, China.
Health Laboratory, Inspection and Quarantine Bureau of Shenzhen City, Shenzhen 518045, Guangdong Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Apr;27(2):557-562. doi: 10.19746/j.cnki.issn.1009-2137.2019.02.040.
To investigate the feasibilily of screening and identifying the red blood cell type alloantibodies by means of surface plasman resonance(SPR) technique so as to provide a new method for detecting the transfusion compatibility of red blood cells.
The RBC antigens for screening the alloantibody were fixed on the SPR chip surface by means of amino coupling method; the analysis conditions of SPR chip were optimized and then the control serum with RBC blood group antibody positive was detected; the performance of SPR chip for detection of serum was analysed; the consistance of rusults detected by SPR technique and microcolum agglutination for clinieal samples of 129 thalasstmia patients with history of lone-term blood transfusion were compared; at the same time, the blood group amtibodies in 7 patients with blood group antibody positive were identified before blood transfusion by using SPR chip so as to select the RBC antigen compatible blood for transfusion; and the efficacy of RBC transfusion was followed up and evaluated.
The repeatability, sensitivity and specificity of SPR chip technique for detecting the blood group alloantibodies all were better. The SPR technique and microcolumn agglutination method were not significant different for screening blood group alloantibodies (χ2 = 0.333, P>0.05), and the overall consistency was 97.2%; the results of SPR technique in 7 patients with positive blood group antibodies were as follows: 3 cases with anti-E, 1 case anti-M, 1 case anti-C, 1 case anti-Jka and 1 case autoantibody, which were consistent with the results of microcolumn agglutination tests, and the compatible red blood cells were selected for transfusion, of which the infusion of 6 cases was effective. In only 1 case the infusion was ineffective because of autoantibody.
For screening and identification of blood group alloantibodies, the performance of SPR chip technique is equivalent to the micro-column agglutination, but the procedure of SPR technique is simpler, faster and high-throughput and label-free, which can meet the basic requirements for rapid screening and identification of blood group alloantibodies before transfusion of red blood cells.
探讨利用表面等离子体共振(SPR)技术筛查和鉴定红细胞血型同种抗体的可行性,为检测红细胞输血相容性提供新方法。
采用氨基偶联法将用于筛查同种抗体的红细胞抗原固定于SPR芯片表面;优化SPR芯片分析条件后检测红细胞血型抗体阳性的对照血清;分析SPR芯片检测血清的性能;比较SPR技术与微柱凝集法检测129例长期输血史地中海贫血患者临床样本的结果一致性;同时利用SPR芯片对7例血型抗体阳性患者输血前进行血型抗体鉴定,以选择红细胞抗原相容的血液进行输血,并对红细胞输血疗效进行随访评估。
SPR芯片技术检测血型同种抗体的重复性、敏感性和特异性均较好。SPR技术与微柱凝集法筛查血型同种抗体差异无统计学意义(χ2 = 0.333,P>0.05),总体一致性为97.2%;7例血型抗体阳性患者的SPR技术检测结果为:抗-E 3例、抗-M 1例、抗-C 1例、抗-Jka 1例、自身抗体1例,与微柱凝集试验结果一致,并选择了相容的红细胞进行输血,其中6例输注有效。仅1例因自身抗体输注无效。
对于血型同种抗体的筛查和鉴定,SPR芯片技术性能与微柱凝集法相当,但SPR技术操作更简单、快速,具有高通量和无需标记的特点,能够满足红细胞输血前快速筛查和鉴定血型同种抗体的基本要求。